GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,123,000 | -60.7% | 492,481 | -59.8% | 0.27% | -62.8% |
| Q3 2020 | $46,067,000 | -14.5% | 1,223,878 | -7.4% | 0.72% | -12.8% |
| Q2 2020 | $53,895,000 | +4.5% | 1,321,268 | -2.9% | 0.83% | -3.9% |
| Q1 2020 | $51,579,000 | -23.9% | 1,361,270 | -5.6% | 0.86% | +8.5% |
| Q4 2019 | $67,773,000 | +6.2% | 1,442,292 | -3.5% | 0.80% | +3.5% |
| Q3 2019 | $63,815,000 | +8.5% | 1,495,199 | +2.8% | 0.77% | +11.3% |
| Q2 2019 | $58,799,000 | +11.8% | 1,454,693 | +15.6% | 0.69% | -10.3% |
| Q1 2019 | $52,595,000 | +2.7% | 1,258,555 | -6.1% | 0.77% | -2.4% |
| Q4 2018 | $51,219,000 | -20.2% | 1,340,467 | -16.1% | 0.79% | -5.3% |
| Q3 2018 | $64,148,000 | -9.3% | 1,596,921 | -9.0% | 0.83% | -8.8% |
| Q2 2018 | $70,705,000 | -3.3% | 1,754,039 | -6.2% | 0.91% | +4.0% |
| Q1 2018 | $73,098,000 | +83.4% | 1,870,961 | +66.5% | 0.88% | +89.6% |
| Q4 2017 | $39,852,000 | -48.3% | 1,123,538 | -40.8% | 0.46% | -50.1% |
| Q3 2017 | $77,117,000 | -10.4% | 1,899,432 | -4.9% | 0.93% | -13.4% |
| Q2 2017 | $86,103,000 | -11.4% | 1,996,833 | -13.4% | 1.07% | -14.2% |
| Q1 2017 | $97,195,000 | +17.4% | 2,305,384 | +7.3% | 1.25% | +11.2% |
| Q4 2016 | $82,764,000 | -21.1% | 2,149,156 | -11.6% | 1.12% | -11.0% |
| Q3 2016 | $104,857,000 | +7.3% | 2,431,178 | +7.9% | 1.26% | +6.2% |
| Q2 2016 | $97,691,000 | +6.4% | 2,254,072 | -0.4% | 1.19% | +5.6% |
| Q1 2016 | $91,772,000 | -4.0% | 2,263,183 | -4.5% | 1.12% | -1.1% |
| Q4 2015 | $95,579,000 | -10.1% | 2,368,752 | -14.3% | 1.14% | -6.8% |
| Q3 2015 | $106,319,000 | -8.6% | 2,765,123 | -1.0% | 1.22% | +1.5% |
| Q2 2015 | $116,357,000 | -9.6% | 2,793,691 | +0.2% | 1.20% | -5.7% |
| Q1 2015 | $128,729,000 | +78.7% | 2,789,356 | +65.5% | 1.28% | +39.8% |
| Q4 2014 | $72,048,000 | -46.2% | 1,685,726 | -42.1% | 0.91% | -28.6% |
| Q3 2014 | $133,815,000 | -9.6% | 2,910,913 | +5.2% | 1.28% | -6.3% |
| Q2 2014 | $147,991,000 | +10.9% | 2,767,216 | +10.8% | 1.36% | +5.4% |
| Q1 2014 | $133,433,000 | +18.7% | 2,497,337 | +18.6% | 1.29% | +16.3% |
| Q4 2013 | $112,431,000 | +23.1% | 2,105,836 | +15.6% | 1.11% | +10.6% |
| Q3 2013 | $91,367,000 | +18.0% | 1,821,140 | +17.6% | 1.01% | +8.8% |
| Q2 2013 | $77,402,000 | – | 1,548,968 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |